Elizabeth Goodrich

Placeholder Person Graphic
MilliporeSigma
Sys Process Eng'g Manager
Elizabeth M. Goodrich is an accomplished bioprocess engineer with over 30 years of experience in protein purification development and scale-up as well as system design and process automation. She currently leads the process technology applications and innovation team at MilliporeSigma, working to develop continuous biomanufacturing solutions that incorporate novel process, analytical, and digital solutions. Elizabeth holds a BS in chemical engineering from the Massachusetts Institute of Technology.

Related Articles

Figure 1: Batch manufacturing process vs. a low pH iVI process.
Technical
Continuous Process: Implementing Low pH Viral Inactivation in a Continuous Process

Viral inactivation (VI) is a critical step in ensuring the safety of monoclonal antibody (mAb), Fc fusion, and recombinant protein therapeutics and it is typically an important component of an overall virus control strategy for downstream biotherapeutic production processes. Considerations for successful implementation of an inline VI process are discussed in this article.